BiotechTube
Home/Eluciderm/Daniel Holsworth, PhD, RAC
DH

Daniel Holsworth, PhD, RAC

Chief Executive Officer & Founder

Eluciderm

Therapeutic Areas

DermatologyWound HealingRegenerative Medicine

Eluciderm Pipeline

DrugIndicationPhase
ELU42Diabetic Foot Ulcers, Burns, Open Traumatic Soft Tissue WoundsPre-clinical